Form D · Manufacturing
SELKIRK PHARMA, INC.
Spokane, WA · CIK 0001732446
Offering snapshot reported Sep 13, 2023 · SEC filing
- Reported sold
- $24.1M Offering amount: $25M
- Investors reported
- 114 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 25, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 13, 2023 | Initial | $24,102,603 | No comparison | 114 | SEC filing |
| Dec 30, 2021 | Initial | $35,000,005 | No comparison | 137 | SEC filing |
| Sep 15, 2020 | Initial | $12,174,000 | No comparison | 79 | SEC filing |
| Feb 25, 2020 | Initial | $9,051,286 | No comparison | 65 | SEC filing |
| Mar 2, 2018 | Initial | $1,725,000 | No comparison | 19 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-492049
Source: Form D, filed Sep 13, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Marshall Crew | Director |
| Patrick Haffey | Director, Executive |
| Joe Herzog | Director, Executive |
| Rod Raabe | Director |
| Tom Tobin | Director |
Issuer details
Industry: Manufacturing (See others in industry)
Address:
9110 W Granite Ave
Spokane, WA, 99224
Spokane, WA, 99224